Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 9, Supplement 2, 1998   [Index by Author] 


Down Preface
Down Background Information
Down Acknowledgements
Down Abstracts: Special Workshops
Down Abstracts: Opening ceremony
Down Abstracts: Lecture sessions
Down Abstracts: Poster sessions
Down Subject Index
Down Authors Index


[Search ALL Issues]

Front Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Preface Back

H.M. Pinedo
Preface
Ann Oncol 1998 9: v; doi:10.1093/annonc/9.suppl_2.v [PDF] [Request Permissions]  

Background Information Back

M.R.L. Krul
NCI-EORTC Symposium on New Drugs in Cancer Therapy
Ann Oncol 1998 9: vi; doi:10.1093/annonc/9.suppl_2.vi [PDF] [Request Permissions]  

C.K. van Kalken
The EORTC New Drug Development Office (NDDO)
Ann Oncol 1998 9: vii; doi:10.1093/annonc/9.suppl_2.vii [PDF] [Request Permissions]  

Acknowledgements Back

Committees
Ann Oncol 1998 9: viii; doi:10.1093/annonc/9.suppl_2.viii-a [PDF] [Request Permissions]  

Financial support
Ann Oncol 1998 9: viii; doi:10.1093/annonc/9.suppl_2.viii-b [PDF] [Request Permissions]  

Abstracts: Special Workshops Back

Molecular targets of cancer chemoprevention
Ann Oncol 1998 9: 1; doi:10.1093/annonc/9.suppl_2.1 [PDF] [Request Permissions]  

Combinatorial chemistry – diversity generation
Ann Oncol 1998 9: 2; doi:10.1093/annonc/9.suppl_2.2 [PDF] [Request Permissions]  

Target based screening
Ann Oncol 1998 9: 3; doi:10.1093/annonc/9.suppl_2.3 [PDF] [Request Permissions]  

Mechanisms of cellular drug uptake
Ann Oncol 1998 9: 4; doi:10.1093/annonc/9.suppl_2.4 [PDF] [Request Permissions]  

Anticancer agents targeting signalling molecules and cancer cell environment
Ann Oncol 1998 9: 5-6; doi:10.1093/annonc/9.suppl_2.5 [PDF] [Request Permissions]  

Dendritic cells as a vehicle for immunization against tumor antigens
Ann Oncol 1998 9: 7; doi:10.1093/annonc/9.suppl_2.7 [PDF] [Request Permissions]  

Drug resistance
Ann Oncol 1998 9: 8; doi:10.1093/annonc/9.suppl_2.8 [PDF] [Request Permissions]  

Abstracts: Opening ceremony Back

Third Michel Clavel lecture; Keynote lectures
Ann Oncol 1998 9: 9; doi:10.1093/annonc/9.suppl_2.9 [PDF] [Request Permissions]  

Abstracts: Lecture sessions Back

Anti-angiogenesis and anti-metastatic agents
Ann Oncol 1998 9: 11; doi:10.1093/annonc/9.suppl_2.11 [PDF] [Request Permissions]  

Common Toxity Criteria (CTC) Version 2.0: Highlights and tools
Ann Oncol 1998 9: 12; doi:10.1093/annonc/9.suppl_2.12 [PDF] [Request Permissions]  

Apoptosis
Ann Oncol 1998 9: 13; doi:10.1093/annonc/9.suppl_2.13 [PDF] [Request Permissions]  

Topoisomerase inhibitors
Ann Oncol 1998 9: 14; doi:10.1093/annonc/9.suppl_2.14 [PDF] [Request Permissions]  

The genetic and molecular basis for chemoprevention
Ann Oncol 1998 9: 15; doi:10.1093/annonc/9.suppl_2.15 [PDF] [Request Permissions]  

Biological approaches
Ann Oncol 1998 9: 16; doi:10.1093/annonc/9.suppl_2.16 [PDF] [Request Permissions]  

New DNA-interactive agents: Is this target alive and well?
Ann Oncol 1998 9: 17; doi:10.1093/annonc/9.suppl_2.17 [PDF] [Request Permissions]  

Interaction with signal transdution pathways
Ann Oncol 1998 9: 18-19; doi:10.1093/annonc/9.suppl_2.18 [PDF] [Request Permissions]  

Tubulin inhibitors: Mechanisms and combinations
Ann Oncol 1998 9: 20; doi:10.1093/annonc/9.suppl_2.20 [PDF] [Request Permissions]  

Discovery and development of two novel oncology drugs: BNP and karenitecins
Ann Oncol 1998 9: 21; doi:10.1093/annonc/9.suppl_2.21 [PDF] [Request Permissions]  

New approaches and cellular targets
Ann Oncol 1998 9: 22; doi:10.1093/annonc/9.suppl_2.22 [PDF] [Request Permissions]  

Novel delivery systems and prodrugs
Ann Oncol 1998 9: 23; doi:10.1093/annonc/9.suppl_2.23 [PDF] [Request Permissions]  

Tumor microenvironment and microcirculation: Role in drug delivery
Ann Oncol 1998 9: 24; doi:10.1093/annonc/9.suppl_2.24 [PDF] [Request Permissions]  

Evaluation of response to treatment in solid tumors: Can the methodology be harmonized and simplified?
Ann Oncol 1998 9: 25; doi:10.1093/annonc/9.suppl_2.25 [PDF] [Request Permissions]  

Gene therapy
Ann Oncol 1998 9: 26; doi:10.1093/annonc/9.suppl_2.26 [PDF] [Request Permissions]  

Abstracts: Poster sessions Back

Drug design, synthesis, acquisition and structure–activity relationships
Ann Oncol 1998 9: 27-33; doi:10.1093/annonc/9.suppl_2.27 [PDF] [Request Permissions]  

Preclinical drug screening
Ann Oncol 1998 9: 34-45; doi:10.1093/annonc/9.suppl_2.34 [PDF] [Request Permissions]  

Formulation research and stability studies
Ann Oncol 1998 9: 46-48; doi:10.1093/annonc/9.suppl_2.46 [PDF] [Request Permissions]  

Preclinical pharmacokinetics
Ann Oncol 1998 9: 49-52; doi:10.1093/annonc/9.suppl_2.49 [PDF] [Request Permissions]  

Toxicology and modulators of toxicity
Ann Oncol 1998 9: 53-57; doi:10.1093/annonc/9.suppl_2.53 [PDF] [Request Permissions]  

Topoisomerase inhibitors
Ann Oncol 1998 9: 58-71; doi:10.1093/annonc/9.suppl_2.58 [PDF] [Request Permissions]  

Angiogenesis inhibitors and anti-metastatic agents
Ann Oncol 1998 9: 72-79; doi:10.1093/annonc/9.suppl_2.72 [PDF] [Request Permissions]  

Biological therapy, immunotherapy and gene therapy
Ann Oncol 1998 9: 80-89; doi:10.1093/annonc/9.suppl_2.80 [PDF] [Request Permissions]  

Tubulin interacting agents
Ann Oncol 1998 9: 90-104; doi:10.1093/annonc/9.suppl_2.90 [PDF] [Request Permissions]  

Signal transduction and apoptosis
Ann Oncol 1998 9: 105-114; doi:10.1093/annonc/9.suppl_2.105 [PDF] [Request Permissions]  

Phase I studies and clinical pharmacokinetic studies
Ann Oncol 1998 9: 115-131; doi:10.1093/annonc/9.suppl_2.115 [PDF] [Request Permissions]  

New drug targets, mechanism of action studies and biochemical pharmacology
Ann Oncol 1998 9: 132-143; doi:10.1093/annonc/9.suppl_2.132 [PDF] [Request Permissions]  

Drug resistance and modifiers
Ann Oncol 1998 9: 144-151; doi:10.1093/annonc/9.suppl_2.144 [PDF] [Request Permissions]  

Antimetabolites
Ann Oncol 1998 9: 152-168; doi:10.1093/annonc/9.suppl_2.152 [PDF] [Request Permissions]  

Phase II studies and other clinical studies
Ann Oncol 1998 9: 169-181; doi:10.1093/annonc/9.suppl_2.169 [PDF] [Request Permissions]  

Subject Index Back

Subject index
Ann Oncol 1998 9: 185-189; doi:10.1093/annonc/9.suppl_2.185 [PDF] [Request Permissions]  

Authors Index Back

Authors index
Ann Oncol 1998 9: 191-211; doi:10.1093/annonc/9.suppl_2.191 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.